Seers Technology

458870 · KQ · Healthcare / Medical Devices

14,070.00KRW+120.00 (+0.86%)

Price History

Full chart

Market Stats

Previous Close13,950.00

Open14,010.00

Day Range14,010.00 – 14,750.00

52-Week Range19,820.00 – 64,199.93

Volume311.76K

Market Cap1.03T

P/E (TTM)0.00

Forward P/E9.29

Dividend Yield0.00%

Beta0.13

50-Day Avg23,861.00

200-Day Avg38,201.08

About

SEERS Co., Ltd. engages in the development, manufacturing, and sales of medical devices in South Korea. It offers wearable biosensor, electrocardiographic holter analyser, thermometer, pulse oximeter, monitoring dashboard, ward managing software, mobile monitoring software, medical AI, and medical adhesive material. The company was formerly known as Seers Technology Co., LTD. The company was founded in 2009 and is headquartered in Pyeongtaek-si, South Korea.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Young-Shin Lee
Employees0
Headquarters291-13, Dongbu-daero, Pyeongtaek-si, South Korea, Korea
Websitehttps://www.seerstech.com

Leadership

Mr. Young-Shin LeeFounder, CEO & Executive Director · b. 1970
Young-Tae JangCFO
Gyu-Seok BangCOO · b. 1968
Dae-yeop KangCSO · b. 1973
Hee-Seok SongCTO · b. 1970
Seong-Jong KimCBO · b. 1978
Sung-won JangExecutive

Financials

Income Statement

Currency: KRW	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.39B	1.15B	1.89B	8.10B	48.17B
Growth (%)	-	-16.82%	+63.50%	+329.69%	+494.72%
Cost of Revenue	1.53B	1.70B	2.71B	4.66B	13.29B
Gross Profit	-143.41M	-551.02M	-824.49M	3.44B	34.88B
Gross Margin	-10.35%	-47.79%	-43.74%	42.42%	72.42%
Operating Expense	4.25B	7.44B	8.98B	12.12B	18.56B
Operating Income	-4.39B	-7.99B	-9.80B	-8.68B	16.33B
Operating Margin	-316.63%	-693.03%	-520.07%	-107.18%	33.89%
EBITDA	-	-7.38B	-8.72B	-7.26B	17.65B
EBITDA Margin	-	-640.45%	-462.47%	-89.67%	36.64%
Net Income	-4.43B	-7.99B	-9.92B	-8.87B	16.09B
Net Income Margin	-319.64%	-692.86%	-526.10%	-109.53%	33.40%
R&D	1.38B	2.83B	3.46B	4.13B	4.56B
R&D as % of Total Revenue	99.34%	245.46%	183.46%	50.99%	9.46%
Interest Expense	131.79M	93.33M	210.46M	391.30M	238.00M
Interest Expense % of Total Revenue	9.51%	8.09%	11.17%	4.83%	0.49%

Balance Sheet

Currency: KRW	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	23.59B	21.29B	17.15B	28.08B	54.20B
Total Liabilities	4.77B	3.28B	9.04B	6.68B	14.58B
Total Equity	18.82B	18.01B	8.11B	21.40B	39.56B
Cash	21.32B	10.30B	4.14B	10.80B	11.10B
Net Debt	-	-	437.74M	-	-

Cash Flow

Currency: KRW	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-4.28B	-8.53B	-7.90B	-11.10B	2.09B
Investing Cash Flow	-	-8.85B	-990.24M	-1.42B	-
Financing Cash Flow	-	6.34B	2.73B	19.18B	-
Capital Expenditure	459.73M	8.84B	687.98M	406.28M	1.63B
Free Cash Flow	-4.74B	-17.37B	-8.58B	-11.51B	454.45M
FCF to OCF	110.73%	203.65%	108.71%	103.66%	21.78%

Earnings

Report Date	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-
EPS Actual	-81.74	-91.69	7.46	-15.72	39.77	177.75	222.21	361.36	330.37
Surprise	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.03T

Enterprise Value932.68B

Trailing P/E0.00

Forward P/E9.29

Price / Sales10.59

Price / Book13.95

Revenue (TTM)97.05B

Gross Profit (TTM)67.48B

EBITDA43.79B

Profit Margin43.15%

Operating Margin45.64%

Return on Equity91.75%

Return on Assets45.07%

Shares Outstanding38.06M

Shares Float24.93M

Beta0.13

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Mar 24, 20263:1